Alex C. Levit - Net Worth and Insider Trading
Alex C. Levit Net Worth
The estimated net worth of Alex C. Levit is at least $137,292 dollars as of 2024-11-07. Alex C. Levit is the Chief Legal Officer, Corp. Sec of Context Therapeutics Inc and owns about 61,983 shares of Context Therapeutics Inc (CNTX) stock worth over $137,292. Details can be seen in Alex C. Levit's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alex C. Levit has not made any transactions after 2022-12-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alex C. Levit
Alex C. Levit Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alex C. Levit owns 1 companies in total, including Context Therapeutics Inc (CNTX) .
Click here to see the complete history of Alex C. Levit’s form 4 insider trades.
Insider Ownership Summary of Alex C. Levit
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CNTX | Context Therapeutics Inc | 2022-12-09 | Chief Legal Officer & Corp. Sec |
Alex C. Levit Latest Holdings Summary
Alex C. Levit currently owns a total of 1 stock. Alex C. Levit owns 61,983 shares of Context Therapeutics Inc (CNTX) as of December 9, 2022, with a value of $137,292.
Latest Holdings of Alex C. Levit
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CNTX | Context Therapeutics Inc | 2022-12-09 | 61,983 | 2.22 | 137,292 |
Holding Weightings of Alex C. Levit
Alex C. Levit Form 4 Trading Tracker
According to the SEC Form 4 filings, Alex C. Levit has made a total of 2 transactions in Context Therapeutics Inc (CNTX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Context Therapeutics Inc is the acquisition of 6,000 shares on December 9, 2022, which cost Alex C. Levit around $5,100.
Insider Trading History of Alex C. Levit
- 1
Alex C. Levit Trading Performance
GuruFocus tracks the stock performance after each of Alex C. Levit's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alex C. Levit is -41.12%. GuruFocus also compares Alex C. Levit's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alex C. Levit within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Alex C. Levit's insider trading performs compared to the benchmark.
Performance of Alex C. Levit
Alex C. Levit Ownership Network
Ownership Network List of Alex C. Levit
Ownership Network Relation of Alex C. Levit
Alex C. Levit Owned Company Details
What does Context Therapeutics Inc do?
Who are the key executives at Context Therapeutics Inc?
Alex C. Levit is the Chief Legal Officer & Corp. Sec of Context Therapeutics Inc. Other key executives at Context Therapeutics Inc include director & Chief Executive Officer Martin A. Lehr , Chief Financial Officer Jennifer Lynn Minai-azary , and Chief Medical Officer Tarek Sahmoud .
Context Therapeutics Inc (CNTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Context Therapeutics Inc (CNTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Context Therapeutics Inc (CNTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Context Therapeutics Inc (CNTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Context Therapeutics Inc Insider Transactions
Alex C. Levit Mailing Address
Above is the net worth, insider trading, and ownership report for Alex C. Levit. You might contact Alex C. Levit via mailing address: 3675 Market Street, Suite 200, Philadelphia Pa 19104.